WallStreetZenWallStreetZen

NASDAQ: SILO
Silo Pharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their SILO stock forecasts and price targets.

Forecast return on equity

Is SILO forecast to generate an efficient return?

Company
-195.27%
Industry
11.71%
Market
329.83%
SILO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SILO forecast to generate an efficient return on assets?

Company
-153.19%
Industry
12.54%
SILO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SILO earnings per share forecast

What is SILO's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.71
Avg 2 year Forecast
-$0.73

SILO revenue forecast

What is SILO's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$73.4k+1.86%
Avg 2 year Forecast
$73.4k+1.86%
SILO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SILO revenue growth forecast

How is SILO forecast to perform vs Biotechnology companies and vs the US market?

Company
1.86%
Industry
9,608.75%
Market
1,453.97%
SILO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SILO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SILO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SILO$0.43N/AN/A
VIVS$2.22N/AN/A
GLMD$1.05N/AN/A
APRE$0.94N/AN/A
CYCN$1.51N/AN/A
View Top Biotech Stocks

Silo Pharma Stock Forecast FAQ

What is SILO's earnings growth forecast for 2025-2026?

(NASDAQ: SILO) Silo Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 207.38%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,953.18%.

Silo Pharma's earnings in 2025 is -$5,076,788.On average, 3 Wall Street analysts forecast SILO's earnings for 2025 to be -$9,509,247, with the lowest SILO earnings forecast at -$9,136,335, and the highest SILO earnings forecast at -$9,788,931.

In 2026, SILO is forecast to generate -$9,780,940 in earnings, with the lowest earnings forecast at -$9,397,373 and the highest earnings forecast at -$10,068,614.

If you're new to stock investing, here's how to buy Silo Pharma stock.

What is SILO's revenue growth forecast for 2025-2026?

(NASDAQ: SILO) Silo Pharma's forecast annual revenue growth rate of 1.86% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 9,608.75%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,453.97%.

Silo Pharma's revenue in 2025 is $72,102.On average, 3 Wall Street analysts forecast SILO's revenue for 2025 to be $978,094, with the lowest SILO revenue forecast at $939,737, and the highest SILO revenue forecast at $1,006,861.

In 2026, SILO is forecast to generate $978,094 in revenue, with the lowest revenue forecast at $939,737 and the highest revenue forecast at $1,006,861.

What is SILO's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: SILO) forecast ROA is -153.19%, which is lower than the forecast US Biotechnology industry average of 12.54%.

What is SILO's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: SILO) Silo Pharma's current Earnings Per Share (EPS) is -$0.95. On average, analysts forecast that SILO's EPS will be -$0.71 for 2025, with the lowest EPS forecast at -$0.69, and the highest EPS forecast at -$0.74. In 2026, SILO's EPS is forecast to hit -$0.73 (min: -$0.71, max: -$0.76).

What is SILO's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: SILO) forecast ROE is -195.27%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.